Johnson & Johnson pauses COVID-19 vaccine trials due to unexplained illness in participant

J&J, which reports quarterly financial results on Tuesday morning, said that such pauses are normal in big trials, which can include tens of thousands of people. It said the “study pause” in giving doses of the vaccine candidate was different from a “regulatory hold” required by health authorities. The current case is a pause.
Read More

Leave a Comment

Your email address will not be published. Required fields are marked *